Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00121355
Status:
COMPLETED
Last Update Posted:
2016-10-18
First Post:
2005-07-13
Brief Title:
Novofine Autocover Safety Needle Versus BD Safety Glide
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
An Open-Label Multi-Center Prospective Cross-Over Study of Preference and Safety of NovoFine AutocoverTM Needles Compared to BD Safety Glide TM Syringes in the Hospital Setting
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is conducted in the United States of America USA The aim of this trial is to examine whether nurses prefer to use the NovoFine Autocover Needle or the BD Safety Glide TM Syringe only in a hospital setting The number of needle stick injuries will also be evaluated and whether these hospital nurses prefer the safety features of the NovoFine Autocover Needle versus those of the BD Safety Glide TM Syringe The identified hospital nurses will evaluate the two types of needles during standard administration of insulin to patients being treated for diabetes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None